GCG and type 2 diabetes mellitus: The success of GLP-1 analogs, therefore, supports the concept that restoring or mimicking the ileal brake constitutes a rational and effective strategy for disrupting the pathogenic cycle of insulin resistance and β-cell dysfunction that underlies T2DM.